Streptozocin Powder, For Solution
Category: Oncology
FDA status: Current · Last FDA update: Sep 16, 2026 · First posted: Jul 12, 2022 (in shortage 4 years 2 months) · 2 manufacturers, 2 listed presentations
As of Sep 16, 2026, the FDA lists Streptozocin Powder, For Solution as currently in shortage. Of 2 manufacturer presentations, 1 Unavailable, 1 Available.
| Presentation & package NDC | Manufacturer | Availability | FDA note |
|---|---|---|---|
| Zanosar, Powder, For Solution, 1 g/10 mL (NDC 68118-100-01) NDC 68118-100-01 |
ESTEVE PHARMACEUTICALS, S.A. | Available | - |
| Zanosar, Powder, For Solution, 100 mg/1 mL (NDC 0703-4636-01) NDC 0703-4636-01 |
Teva Pharmaceuticals USA, Inc. | Unavailable | Estimated recovery: TBD |
Related medications in shortage
Other Oncology medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.
Change log
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Cite this: “FDA drug-shortage status for Streptozocin Powder, For Solution (FDA data as of Sep 16, 2026). Shortage Watch, openFDA.”
Get an email when this record changes
One email, only when the FDA changes something for Streptozocin Powder, For Solution. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.
Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.
Embed a live status badge: /badge/streptozocin-powder-for-solution.svg
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).